Skip to contentL
Lifecore Biomedical, Inc.
L
LFCRLifecore Biomedical, Inc. Q3 2015 · 10-Q
Revenue$138.53M$138.53M+9.6% vs Q3 2014 Net Income$3.77M$3.77M−41.1% vs Q3 2014 EPS Diluted$0.14$0.14−41.7% vs Q3 2014 Gross Profit$16,885,000−16.2% Operating Income
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Lifecore Biomedical, Inc. · CIK 1005286 · Engraved from SEC EDGAR
Margins · derivedGross margin12.2%−3.8 pt vs Q3 2014
Operating margin3.5%−4.2 pt vs Q3 2014
Net margin2.7%−2.3 pt vs Q3 2014
ended Mar 1, 2015 · filed Apr 2, 2015 · 32 d after period end